NCT07268638Phase 2Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Study sponsor: Akebia Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-06Estimated
Enrollment · participants60Estimated
Source updated2026-08-13Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status

Recorded edit
− Previous value

Not yet recruiting

+ Updated value

Recruiting

Check registry source